2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Who cites it

1,788 citing papers in PubMed, 9 syntheses or guidelines pooled it.

1. [Practical guideline on the prevention and management of diabetic foot in China (Ⅰ)].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2025
   Guideline
2. Does Medication Status Impact the Effectiveness of Nuts in Altering Blood Pressure and Lipids? A Systematic Review and Meta-Analysis.Nutrition reviews · 2025
   Pooled it
3. The effect of magnesium supplementation on serum concentration of lipid profile: an updated systematic review and dose-response meta-analysis on randomized controlled trials.Nutrition journal · 2025
   Pooled it
4. Statin Therapy and C-reactive Protein in Patients with Kidney Disease: A Systematic Review and Meta-analysis of Randomized Clinical Trials.Current drug targets · 2025
   Pooled it
5. Zinc Supplementation in Individuals with Prediabetes and type 2 Diabetes: a GRADE-Assessed Systematic Review and Dose-Response Meta-analysis.Biological trace element research · 2024
   Pooled it
6. Tracking of apolipoprotein B levels measured in childhood and adolescence: systematic review and meta-analysis.European journal of pediatrics · 2024
   Pooled it
7. Mobile health apps for cardiovascular risk assessment: a systematic review.Frontiers in cardiovascular medicine · 2024
   Pooled it
8. Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Control Trials.Current pharmaceutical design · 2024
   Pooled it
9. Traditional Chinese medicine lowering lipid levels and cardiovascular events across baseline lipid levels among coronary heart disease: a meta-analysis of randomized controlled trials.Frontiers in cardiovascular medicine · 2024
   Pooled it
10. Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double-blind, multicenter, therapeutic confirmatory, phase III clinical trial.Journal of clinical hypertension (Greenwich, Conn.) · 2024
    Trial
11. Effect of dolutegravir on 'Life's Simple 7' cardiovascular risk factors: A longitudinal analysis from Tanzania.HIV medicine · 2026
    Article
12. The Cog-Aging: a 15-year cohort study of cognition in Brazilian older adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
13. Interferon Regulatory Factors as Potential Therapeutic Targets in Cardiovascular Disease: Focusing on Vascular Inflammation.International journal of molecular sciences · 2026
    Review
14. Association of long-term exposure to lower low-density lipoprotein cholesterol with neuroimaging metrics: A population-based cohort study.Chinese medical journal · 2026
    Observational
15. Comparative Assessment of Fasting and Stimulated C-peptide Levels as Discriminatory Markers of Coronary Artery Disease in Type 2 Diabetes Mellitus: A Cross-Sectional Study.Cureus · 2026
    Article
16. Impact of PREVENT Cardiovascular Risk Equations on Statin Eligibility by Subgroup and Risk Thresholds: A Cross-Sectional Study.Journal of general internal medicine · 2026
    Article
17. Use of plozasiran across a spectrum of hypertriglyceridemia: Long-term efficacy and safety data from the open-label extension period of SHASTA-2 and MUIR Trials.American journal of preventive cardiology · 2026
    Article
18. Relationship between dietary selenium intake and hyperlipidemia: a population-based study from NHANES (2011-2018).Irish journal of medical science · 2026
    Article
19. Dyslipidemia Management in the Middle East: Recommendations for Overcoming Challenges and Enhancing Outcomes With Pitavastatin.Cureus · 2026
    Review
20. Brain, benefit, or burden? Revisiting statins and cognitive function in older adults.GeroScience · 2026
    Review

1,728 more citing papers are in PubMed but not listed here.

Corrections and comments

• Commented on by
  2013 ACC/AHA Guideline: a guideline for the population - without evidence from the population.2014
• Commented on by
  Is myopathy the Achilles' heel of statins?: differences between the new cholesterol treatment guidelines and everyday clinical practice.2014
• Commented on by
  Reply: is myopathy the achilles' heel of statins?: differences between the new cholesterol treatment guidelines and everyday clinical practice.2014
• Commented on by
  Measurement of low-density lipoprotein cholesterol in assessment and management of cardiovascular disease risk.2014
• Commented on by
  Review of article: Statins: the good, the bad, and the unknown by Gordon H. Sun, MD, MS.2014
• Commented on by
  Navigating patient preference and guidelines as a fellow.2015
• Commented on by
  Response: “Actually, it’s more of a guideline than a rule”.2015
• Commented on by
  Low-density lipoprotein cholesterol goals: still not in patients' best interest.2016
• Erratum issued
• Erratum issued

Authors and funding

17 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as